NEXPLANON

organon canada inc.🇨🇦 Health Canada

Approval Id: 8ac5086bee701653
Drug Approval Canada Name: NEXPLANON
Product Name: NEXPLANON
Status: Marketed
Status Date: 2022-09-08
Original Market Date: 2020-08-17
Din: 02499509
Drug Class: Human
Dosage Form: Implant
Route Of Administration: Subcutaneous
Schedule: Prescription
Ahfs: 68:12.00
Atc Original: G03AC08 ETONOGESTREL
Atc Name: g 03 ac 08
Aig Number: 0162274001
Company Name: organon canada inc.
Company Address: 300, 16766 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7

ETONOGESTREL

68 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8ac5086bee701653

Type

Standard